loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Clinical Development / Phase IIb-IV? Find Clinical Trials & other pharma service details on PharmaCompass.

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 17Bioavailability / Bioequivalence

    02 10Pharmacokinetics / Pharmacodynamics / Pharmacometrics

    03 4Phase I / IIa

    04 13Phase II / III

    05 13Phase IV

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    Learn More #LearnMore
    price-trend Ask Us

    01

    Cohance Lifesciences

    Flag India
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Pharma Service : Clinical Trials

    BIOAVAILABILITY & BIOEQUIVALENCE STUDIES

    Cohance Lifesciences, through its CRBio division, is a leading provider of end-to-end clinical research and bioanalytical solutions in the area of bioavailability and bioequivalence studies.

    arrow

    Category : Clinical Development / Phase IIb-IV

    Sub Category : Bioavailability / Bioequivalence

    Pharma Service : Clinical Trials

    Cohance Bioavailability & Bioequivalence Studies

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    02

    Quantys Clinical

    Flag India
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Pharma Service : Clinical Trials

    BIOAVAILABILITY & BIOEQUIVALENCE STUDIES

    Quantys offers clinical trial services for Phase I and Phase II including bioavailability and bioequivalence studies, drug-drug interactions, steady state, dose-response, food effect, partial or full replicate-design, IVIVC, and blinded studies.

    arrow

    Category : Clinical Development / Phase IIb-IV

    Sub Category : Bioavailability / Bioequivalence

    Pharma Service : Clinical Trials

    Bioavailability & Bioequivalence Studies

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    03

    Olpha

    Flag Latvia
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

    Pharma Service : Clinical Trials

    BIOEQUIVALENCE CLINICAL STUDIES

    Olpha annually carries out various clinical studies (bioequivalence, efficacy, safety studies) in several countries in accordance with the applicable EU and national laws following the Guidelines for Good Clinical Practice (GCP).

    arrow

    Category : Clinical Development / Phase IIb-IV

    Sub Category : Bioavailability / Bioequivalence

    Pharma Service : Clinical Trials

    Bioequivalence Clinical Studies

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    04

    Quotient Sciences

    Flag United Kingdom
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothQuotient Sciences- Molecule to Cure. Fast.

    Pharma Service : Clinical Trials

    BIOAVAILABILITY & BIOEQUIVALENCE STUDIES

    Quotient Sciences has the experience and expertise to seamlessly deliver several studies involving bioavailability, dose proportionality, relative bioavailability, bioequivalence, food effect, thorough QT (TQT), biosimilars, pharmacodynamics, etc.

    arrow

    Category : Clinical Development / Phase IIb-IV

    Sub Category : Bioavailability / Bioequivalence

    Pharma Service : Clinical Trials

    Bioavailability & Bioequivalence Studies

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    05

    Cohance Lifesciences

    Flag India
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Pharma Service : Clinical Trials

    PHASE I & II CLINICAL TRIAL SERVICES

    Cohance Lifesciences has extensive capabilities in handling complex studies and conducting BA and BE studies (including patient-based BA and BE studies, end point and Phase 1b, 2a clinical trials) through its CRBio division.

    arrow

    Category : Clinical Development / Phase IIb-IV

    Sub Category : Phase I / IIa

    Pharma Service : Clinical Trials

    Phase I & II Clinical Trial Services

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    06

    Quantys Clinical

    Flag India
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Pharma Service : Clinical Trials

    PHASE I & PHASE II CLINICAL TRIAL SERVIC...

    Quantys has the capability to undertake Phase I and Phase II clinical trial services such as investigator and site selection, site initiation and management, regulatory and ethics approval, safety reporting, and study monitoring and project management.

    arrow

    Category : Clinical Development / Phase IIb-IV

    Sub Category : Phase I / IIa

    Pharma Service : Clinical Trials

    Phase I & Phase II Clinical Trial Services

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    07

    Quantys Clinical

    Flag India
    arrow
    BIO CEO & Investor
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Pharma Service : Clinical Trials

    PHASE II CLINICAL TRIAL SERVICES

    Quantys has considerable experience in conducting Phase I and Phase II clinical trial services including investigator and site selection, data management, statistical analysis and report preparation, and audit and compliance.

    arrow

    Category : Clinical Development / Phase IIb-IV

    Sub Category : Phase II / III

    Pharma Service : Clinical Trials

    Phase II Clinical Trial Services

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Digital Content

    Virtual Booth

    08

    Greenleaf Health Inc

    PREMARKET PREPARATION

    arrow
    BIO CEO & Investor
    Not Confirmed

    09

    Reliance Clinical Testing Services, Inc

    HUMAN REPEAT INSULT PATCH TEST (HRIPT)

    arrow
    BIO CEO & Investor
    Not Confirmed

    10

    Chiltern International Ltd

    CLINICAL DEVELOPMENT SERVICES & SOLUTION...

    arrow
    BIO CEO & Investor
    Not Confirmed

    11

    TFS International AB

    PK / PD MODELLING & SIMULATION

    arrow
    BIO CEO & Investor
    Not Confirmed

    12

    Greenleaf Health Inc

    PREMARKET SUBMISSIONS

    arrow
    BIO CEO & Investor
    Not Confirmed

    13

    Chiltern International Ltd

    CLINICAL DEVELOPMENT SERVICES & SOLUTION...

    arrow
    BIO CEO & Investor
    Not Confirmed

    14

    Reliance Clinical Testing Services, Inc

    CLAIMS SUBSTANTIATION & EFFICACY TESTING

    arrow
    BIO CEO & Investor
    Not Confirmed

    15

    Evidera

    INTERVENTIONAL STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    16

    Greenleaf Health Inc

    MARKETING & PROMOTIONAL PRACTICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    17

    Celerion

    PHARMACOKINETICS / PHARMACODYNAMICS (PK/...

    arrow
    BIO CEO & Investor
    Not Confirmed

    18

    Celerion

    GENERIC DRUGS / BIOSIMILARS

    arrow
    BIO CEO & Investor
    Not Confirmed

    19

    MPI Research Inc

    SUPPORTING DRUG DEVELOPMENT AT PHASE IV

    arrow
    BIO CEO & Investor
    Not Confirmed

    20

    Spaulding Clinical, LLC

    NON-COMPARTMENTAL PK & PD ANALYSIS

    arrow
    BIO CEO & Investor
    Not Confirmed

    21

    Spaulding Clinical, LLC

    TOXICOKINETIC ANALYSIS & BIOANALYTICAL D...

    arrow
    BIO CEO & Investor
    Not Confirmed

    22

    Spaulding Clinical, LLC

    PK REPORTS

    arrow
    BIO CEO & Investor
    Not Confirmed

    23

    Celerion

    BIOSIMILARS

    arrow
    BIO CEO & Investor
    Not Confirmed

    24

    Spaulding Clinical, LLC

    POPULATION PK ANALYSIS

    arrow
    BIO CEO & Investor
    Not Confirmed

    25

    Nutrasource

    PHASE II & PHASE III CLINICAL TRIALS

    arrow
    BIO CEO & Investor
    Not Confirmed

    26

    PPD

    CLINICAL DEVELOPMENT SERVICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    27

    PPD

    PHASE IV MONITORED TRIALS

    arrow
    BIO CEO & Investor
    Not Confirmed

    28

    PAREXEL International Corporation

    PHASE LL-LLL

    arrow
    BIO CEO & Investor
    Not Confirmed

    29

    PAREXEL International Corporation

    PHASE LLLB-LV

    arrow
    BIO CEO & Investor
    Not Confirmed

    30

    Prague Scientific

    PK & PD ANALYSIS

    arrow
    BIO CEO & Investor
    Not Confirmed

    31

    QUINTA-ANALYTICA s.r.o

    PHASE I CLINICAL TRIALS & BE/BA STUDY

    arrow
    BIO CEO & Investor
    Not Confirmed

    32

    Dalmia

    BIOAVAILABILITY / BIOEQUIVALENCE STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    33

    AVM Biotechnology

    PHASE I & II CLINICAL TRIAL SERVICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    34

    Azidus Laboratories

    BIOAVAILABILITY / BIOEQUIVALENCE STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    35

    ICBio Clinical Research Pvt Ltd

    BIOAVAILABILITY & BIOEQUIVALENCE STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    36

    Azidus Laboratories

    PHARMACOKINETICS / PHARMACODYNAMICS STUD...

    arrow
    BIO CEO & Investor
    Not Confirmed

    37

    AVM Biotechnology

    CLINICAL TRIAL SERVICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    38

    ICBio Clinical Research Pvt Ltd

    PK / PD PATIENT STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    39

    Prorelix Research

    PHASE IV CLINICAL RESEARCH SERVICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    40

    Lamda Laboratories

    CLINICAL DEVELOPMENT SERVICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    41

    Azidus Laboratories

    PHASE II / III STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    42

    Navitas Inc

    BIOAVAILABILITY & BIOEQUIVALENCE STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    43

    Amarin Technologies

    BIOAVAILABILITY & BIOEQUIVALENCE STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    44

    Dalmia

    PHASE II & PHASE III CLINICAL TRIALS

    arrow
    BIO CEO & Investor
    Not Confirmed

    45

    Dalmia

    PHASE IV CLINICAL TRIAL

    arrow
    BIO CEO & Investor
    Not Confirmed

    46

    Cliantha Research

    CLINICAL BIOSTATISTICS & PROGRAMMING SER...

    arrow
    BIO CEO & Investor
    Not Confirmed

    47

    Navitas Inc

    BIOLOGICS & BIOSIMILARS STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    48

    Azidus Laboratories

    PHASE IV STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    49

    Cliantha Research

    PHASE I - IV CLINICAL TRIAL SERVICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    50

    Arcinova

    CLINICAL DEVELOPMENT SERVICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    51

    Nuvisan GmbH

    BIOAVAILABILITY & BIOEQUIVALENCE STUDIES

    arrow
    BIO CEO & Investor
    Not Confirmed

    52

    Cliantha Research

    PHASE II/III CLINICAL TRIALS SERVICES

    arrow
    BIO CEO & Investor
    Not Confirmed

    53

    Cliantha Research

    PHARMACOKINETIC STUDIES FOR CLINICAL TRI...

    arrow
    BIO CEO & Investor
    Not Confirmed

    54

    ICBio Clinical Research Pvt Ltd

    PHASE II - PHASE IV CLINICAL TRIALS

    arrow
    BIO CEO & Investor
    Not Confirmed

    55

    Lonza Capsugel

    SPECIALIZED CLINICAL CAPSULES: PHASE I /...

    arrow
    BIO CEO & Investor
    Not Confirmed

    56

    Lonza Capsugel

    SPECIALIZED CLINICAL CAPSULES: PHASE IIB...

    arrow
    BIO CEO & Investor
    Not Confirmed

    57

    Lonza Capsugel

    SPECIALIZED CLINICAL CAPSULES: PHASE II ...

    arrow
    BIO CEO & Investor
    Not Confirmed